Associate Professor, Medicine, Brown University Program in Medicine
Infectious Disease
Dr. Karen T. Tashima, MD
|
|
Give Review
Karen T. Tashima, MD is an expert in the field of Infectious Disease. She went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is one of the top medical schools in the US. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine She has 1 awards "Fellow (FACP)". Dr. Karen T. Tashima is a published physician. She has 90 publications published. The most current publication "Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care." She accepts all Medicare patients.
Publications
- Candida and cardiovascular implantable electronic devices: a case of lead and native aortic valve endocarditis and literature review.
- Facial emotion recognition impairments are associated with brain volume abnormalities in individuals with HIV.
- Plasma Cytokine Levels are Related to Brain Volumes in HIV-infected Individuals.
- Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals.
- Verbal memory declines more rapidly with age in HIV infected versus uninfected adults.
- Factors Associated with Variability in Rifampin Plasma Pharmacokinetics and the Relationship between Rifampin Concentrations and Induction of Efavirenz Clearance.
- Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV.
- Effects of HIV and Early Life Stress on Amygdala Morphometry and Neurocognitive Function.
- The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.
- Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History.
- Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia.
- Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients.
- Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
- Clinical contributors to cerebral white matter integrity in HIV-infected individuals.
- Change in High-Sensitivity C-Reactive Protein Levels Following Initiation of Efavirenz-Based Antiretroviral Regimens in HIV-Infected Individuals.
- Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteers.
- Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.
- Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island.
- Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.
- Facial emotion recognition impairments in individuals with HIV.
- Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients.
- X marks the spot: cosmetic surgery gone awry.
- Motivation and patch treatment for HIV+ smokers: a randomized controlled trial.
- Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral l...
- Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
- Spontaneous perforation of the terminal ileum in an AIDS patient on highly active antiretroviral therapy with disseminated non-tuberculous mycobacterial infection.
- AIDS-related lymphomas: the Rhode Island experience.
- Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection.
- HIV-positive smokers considering quitting: differences by race/ethnicity.
- A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.
- Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).
- Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus.
- Once-daily therapies for the treatment of HIV infection.
- Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir.
- A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antire...
- Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.
- Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.
- Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of...
- Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens.
- Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus.
- Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
- Treating HIV encephalopathy with antiretroviral therapy: a clinical case demonstrating the success of HAART.
- Racial differences in serum lipids in HIV+ women treated with protease inhibitor regimens.
- Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.
- Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of...
- Prevention of HIV transmission after health care worker occupational exposure.
- Fusion inhibition--a major but costly step forward in the treatment of HIV-1.
- Internet sex-seeking leads to acute HIV infection: a report of two cases.
- The impact of apathy and depression on quality of life in patients infected with HIV.
- Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens.
- Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals.
- Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma.
- Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1.
- Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment.
- Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.
- A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use.
- Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: a 3.5-year study.
- Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV.
- Effect of prior nucleoside use on the two-year virological response to an initial protease inhibitor regimen in HIV-infected patients.
- Photo quiz. Disseminated Rhodocuccus equi infection.
- Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life.
- Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.
- Susac''s syndrome: beneficial effects of corticosteroid therapy in a Japanese case.
- Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: a study on Swedish transplanted and non-transplanted patients.
- Diagnosis of acute HIV infection: it's time to get moving!
- Sustained responses to dual nucleoside therapy in women.
- Antiretroviral therapy in the year 2000.
- Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now.
- Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience.
- Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 0...
- Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients.
- Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment.
- Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.
- Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy.
- Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C.
- Identification of a new transthyretin variant (Ile49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and nonisotopic RNase clea...
- Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis.
- Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART).
- Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care.
- Cerebrospinal fluid levels of antiretroviral medications: abstract and commentary.
- Factors associated with vaginal yeast infections in HIV-positive women.
- Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA.
- Management of indinavir associated nephrolithiasis.
- Phase variation in tcpH modulates expression of the ToxR regulon in Vibrio cholerae.
- Indinavir nephropathy.
- Relative importance of three iron-regulated outer membrane proteins for in vivo growth of Vibrio cholerae.
- Update of HIV and AIDS in North America.
- Change in the age of onset in patients with familial amyloidotic polyneuropathy type I.
- Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation.
Schools
Columbia Univ Coll Of Physicians and Surgeons
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Fellow (FACP)
Education
-
Massachusetts General Hospital -
New York Presbyterian Hospital - Columbia Campus -
Columbia University College of Physicians & Surgeons
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1396740551 | |
| NPPES Provider LastName | TASHIMA | |
| NPPES Provider FirstName | KAREN | |
| NPPES Provider ZIPCode | 029062853 | |
| NPPES Provider State | RI | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 2587.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 65.0 | |
| Percent Opioid Claims | 2.51 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396740551 |
| Last Name Of The Provider | TASHIMA |
| First Name Of The Provider | KAREN |
| View All |
Similar Doctors
|
|
Dr. Tamim Hinedi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pilar Alonso, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Linsey D. Philip, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sam T. Donta, MD
This Doctor is OpenDoctor Recommended.
|